The results could open the door to new targeted therapies for this debilitating disease in the future
In the largest study of its kind, nine novel genes for osteoarthritis have been discovered by scientists from the Wellcome Sanger Institute and their collaborators. Results of the study, published today (19 March) in Nature Genetics, could open the door to new targeted therapies for this debilitating disease in the future.
Almost nine million people in the UK suffer from osteoarthritis, a degenerative joint disease in which a person’s joints become damaged, stop moving freely and become painful. Osteoarthritis is the most prevalent musculoskeletal disease and a leading cause of disability worldwide.
There is no treatment for osteoarthritis. The disease is managed with pain relief and culminates in joint replacement surgery, which has variable outcomes.
In the largest study of its kind, scientists from the Wellcome Sanger Institute and their collaborators* investigated the genetics behind osteoarthritis, as well as the diseases and traits that are linked to it.
To understand more about the genetic basis of osteoarthritis, the team studied 16.5 million DNA variations from the UK Biobank resource. Following combined analysis in up to 30,727 people with osteoarthritis and nearly 300,000 people without osteoarthritis in total – the controls – scientists discovered nine new genes that were associated with osteoarthritis, a significant result for this disease.
“Osteoarthritis is challenging to study because the disease can vary among people, and also between the different joints affected, for example knee, hip, hand and spine. Using data from the UK Biobank resource, we have undertaken the largest genetic study of osteoarthritis to date and uncovered nine new genes associated with the disease.”
Professor Eleftheria Zeggini, senior author from the Wellcome Sanger Institute
Researchers then investigated the role of the nine new genes in osteoarthritis, by studying both normal cartilage and diseased cartilage from individuals who had a joint replacement.
The team looked for genes that were active in the progression of the disease by extracting the relevant cells from healthy and diseased tissue, studying the levels of proteins in the tissue and sequencing the RNA – the messenger that carries instructions from DNA for controlling the production of proteins.
Of the nine genes associated with osteoarthritis, researchers identified five genes in particular that differed significantly in their expression in healthy and diseased tissue. The five genes present novel targets for future research into therapies.
“These results are an important step towards understanding the genetic causes of osteoarthritis and take us closer to uncovering the mechanism behind the disease. Once we know that, it opens the door to developing new therapies for this debilitating disease.”
Ms Eleni Zengini, joint first author from the University of Sheffield and Dromokaiteio Psychiatric Hospital in Athens
The team also explored genetic correlations between osteoarthritis and obesity, bone mineral density, type 2 diabetes, and raised blood lipid levels.
Researchers applied a statistical technique known as causal inference analysis to uncover which traits and diseases cause osteoarthritis, and which do not.
Within the limits of their study, scientists discovered that type 2 diabetes and high levels of lipids in the blood do not have causal effects on osteoarthritis, but reaffirm that obesity does.
“Using genetic data, we have shown that type 2 diabetes and increased blood lipid levels do not appear to be on the causal path to osteoarthritis. We also reconfirmed that obesity is on the causal path to osteoarthritis.”
Dr Konstantinos Hatzikotoulas, joint first author from the Wellcome Sanger Institute
“The discovery of these genes is positive news for the 8.5 million people in the UK living with osteoarthritis. People living with this debilitating condition currently have limited treatment options. Meanwhile, they can struggle to do the day-to-day things most of us take for granted, like going to work or getting dressed independently. By revealing how these genes contribute to osteoarthritis, this research could open the door for new treatments to help millions of people live the pain free life they deserve.”
Dr Natalie Carter, Head of research liaison & evaluation at Arthritis Research UK, who did not fund the study
Learn more: New osteoarthritis genes discovered
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- Analysis of genetically independent phenotypes identifies shared genetic factors associated with chronic musculoskeletal pain conditionson June 25, 2020 at 2:20 am
Yakov Tsepilov, Maxim Freidin et al. find that chronic musculoskeletal pain conditions at four distinct anatomical sites share a common genetic background. The authors constructed genetically ...
- New drug trial reveals potential to lessen effects of osteoarthritison June 18, 2020 at 5:13 pm
A trial drug has been found to dampen the effects of osteoarthritis, according to a study conducted by researchers at the University of Liverpool.
- Cynata Announces Ethics Approval and Expedited Regulatory Pathway for Phase 3 Osteoarthritis Clinical Trialon June 18, 2020 at 5:09 am
Dr Kilian Kelly, Cynata's Chief Operating Officer, commented: "We are delighted to gain ethics approval for this important Phase 3 clinical trial in osteoarthritis patients. Approval by the HREC is a ...
- CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Painon June 16, 2020 at 5:35 am
CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that it completed early enrollment of 159 patients in the FDA-regulated clinical ...
- Osteoarthritis Drug Market 2020 : Industry Outlook, Regional Analysis and Forecast 2026on June 15, 2020 at 12:58 am
Osteoarthritis Drug Market Report has recently added by Value Market Research, this surveillance report establishing the facts based on current scenarios, historical records from 2019 to future ...
- 2020 Market Spotlight on Osteoarthritis and Osteoarthritis Pain - ResearchAndMarkets.comon June 10, 2020 at 6:20 am
DUBLIN--(BUSINESS WIRE)--The "Market Spotlight: Osteoarthritis and Osteoarthritis Pain" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the ...
- Tramadol Mortality Risk in Osteoarthritis Could Outweigh Benefitson June 8, 2020 at 2:41 am
According to a recent Cochrane review there is "moderate-quality evidence" that tramadol "has no important benefit on mean pain or function in people with osteoarthritis." The authors of the ...
- Global Osteoarthritis Drugs Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2026on June 7, 2020 at 1:41 am
Global Osteoarthritis Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 equipped with market data from 2015 to 2026. The report comprises the past, current, and ...
- Another Trial Dumps on HCQ in Osteoarthritis of the Handon June 5, 2020 at 1:19 pm
The latest randomized trial of hydroxychloroquine (HCQ) may be the final nail in the coffin for the drug as a treatment for osteoarthritis (OA) of the hand. Among 153 people with inflammatory and ...
via Bing News